Mortality | Yes (n = 13) | No (n = 31) | P value |
---|---|---|---|
Male gender (%) | 46.2% | 58.1% | 0.469 |
Age (years) | 72.8 (10.3) | 69.77 (11.9) | 0.832 |
ASA 3 (%) | 23.1% | 90.3% | < 0.001 |
DM (%) | 53.8% | 70.9% | 0.118 |
Cardiac (%) | 92.3% | 87.1% | 0.619 |
Renal failure (%) | 46.1% | 35.5% | 0.507 |
Neoplasm (%) | 0% | 19.4% | 0.088 |
Obesity (%) | 7.7% | 9.8% | 0.834 |
COPD (%) | 15.4% | 9.68% | 0.586 |
Etiology—Embolic (%) | 15.39% | 32.26% | 0.252 |
Open surgical approach (%) | 61.54% | 61.29% | 0.998 |
Bowel resection (%) | 61.54% | 38.71% | 0.141 |
Second-look laparotomy (%) | 30.78% | 25.8% | 0.736 |
Leukocytes (gpt/l) Mean (SD) | 13.9 (7.8) | 20.17 (13.64) | 0.465 |
CRP (mg/l) Mean (SD) | 89.49 (94.66) | 107.1 (130.23) | 0.603 |
Lactate (mmol/l) Mean (SD) | 4.51 (3.33) | 4.38 (5.935) | 0.272 |
surgery duration (min) Mean (SD) | 148.38(113) | 94.4 (61.2) | 0.482 |
ICU Stay (d) | 10 (12.92) | 5.97 (12) | 0.05 |
Hospital stay (d) | 13.85 (15.4) | 26.35 (23.5) | 0.144 |
Morbidity | Yes (n = 34) | No (n = 10) | P value |
---|---|---|---|
Male Gender (%) | 60% | 52.9% | 0.694 |
Age (years) | 72.1 (11.3) | 65.8 (11.1) | 0.283 |
ASA 3 (%) | 67.6% | 80% | 0.452 |
DM (%) | 38.2% | 30% | 0.634 |
Cardiac (%) | 85% | 100% | 0.198 |
Renal Failure (%) | 35.3% | 50% | 0.401 |
Neoplasm (%) | 11.8% | 20% | 0.505 |
Obesity (%) | 11.7% | 0% | 0.255 |
COPD (%) | 11.8% | 10% | 0.877 |
Etiology—Embolic (%) | 29.4% | 20% | 0.557 |
Open surgical approach (%) | 67% | 40% | 0.114 |
Bowel resection (%) | 55.8% | 10% | 0.065 |
Second-look laparotomy (%) | 20.5% | 50% | 0.066 |
Leukocytes (gpt/l) Mean (SD) | 19.98 (1.72) | 12.66 (13.86) | 0.601 |
CRP (mg/l) Mean (SD) | 110.9 (124.8) | 71.1 (101.56) | 0.307 |
Lactate (mmol/l) Mean (SD) | 4.64 (4.71) | 3.66 (7.065) | 0.293 |
surgery duration (min) Mean (SD) | 125.2 (80.07) | 62.7 (76.9) | 0.36 |
ICU Stay (d) Mean (SD) | 7.79 (13.298) | 5 (8.138) | 0.352 |
Hospital stay (d) Mean (SD) | 26.6 (23.14) | 9.2 (9.331) | 0.494 |